EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Healthcare resource use and costs associated with the misdiagnosis of migraine

Jae Rok Kim, Tae Jin Park, Maria Agapova, Andrew Blumenfeld, Jonathan H Smith, Darshini Shah, Beth Devine

Headache: The Journal of Head and Face Pain · 2025-01 · 65 (1) · 35-44

DOI: 10.1111/head.14822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, online erschienen am 28.08.2024. Verfasst von Jae Rok Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Washington CHOICE Institute, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Migraine Disorders, Diagnostic Errors, Health Care Costs, Patient Acceptance of Health Care. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AbbVie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare healthcare resource utilization and healthcare costs in patients with migraine with or without a history of misdiagnosis.

Background

Despite the high prevalence of migraine, migraine is commonly misdiagnosed. The healthcare resource use and cost burden of a misdiagnosis is unknown.

Methods

This retrospective cohort study identified adults with an incident migraine diagnosis from the Merative™ Marketscan® Commercial and Medicare Supplemental Databases between June 2018 and 2019. Patients with a diagnosis of commonly considered misdiagnoses (headache, sinusitis, or cervical pain) before their migraine diagnosis were classified as the “misdiagnosed cohort.” Patients in the misdiagnosed cohort were potentially misdiagnosed, then eventually received a correct diagnosis. Patients without a history of commonly considered misdiagnoses prior to their migraine diagnosis were classified as the “correctly diagnosed cohort.” Healthcare resource utilization and healthcare costs were assessed in the period before migraine diagnosis and compared between the cohorts. Outcomes were reported as per patient per month and compared with incidence rate ratios.

Results

A total of 29,147 patients comprised the correctly diagnosed cohort and 3841 patients comprised the misdiagnosed cohort and met the inclusion criteria. Patients in the misdiagnosed cohort had statistically significantly higher rates of inpatient admissions (0.02 vs. 0.01, incidence rate ratio [IRR] 1.61, 95% confidence interval [CI] 1.47–1.74), emergency department visits (0.10 vs. 0.05; IRR 1.89, 95% CI 1.79–1.99), neurologist visits (0.12 vs. 0.02; IRR 5.95, 95% CI 5.40–6.57), non‐neurologist outpatient visits (2.64 vs. 1.58; IRR 1.67, 95% CI 1.62–1.72) and prescription fills (2.82 vs. 1.84; IRR 1.53, 95% CI 1.48–1.58) compared to correctly diagnosed patients. Misdiagnosed patients had statistically significantly higher rates of healthcare cost accrual for inpatient admissions ($1362 vs. $518; IRR 2.62, 95% CI 2.50–2.75), emergency department visits ($222 vs. $98; IRR 2.27, 95% CI 2.18–2.36), neurologist visits ($42 vs. $9; IRR 4.39, 95% CI 4.00–4.79), non‐neurologist outpatient visits ($1327 vs. $641; IRR 2.07, 95% CI 1.91–2.24), and prescription fills ($305 vs. $215; IRR 1.41, 95% CI 1.18–1.70) compared to correctly diagnosed patients.

Conclusion

Patients with migraine who have a history of misdiagnoses have higher rates of healthcare resource utilization and cost accrual versus those without such history.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersDiagnostic ErrorsHealth Care CostsPatient Acceptance of Health CareHealth ResourcesHumansFemaleMaleRetrospective StudiesAdultMiddle AgedUnited StatesYoung AdultCohort StudiesHospitalization

Stichwörter der Autor:innen

Headachehealthcare costshealthcare resource usemigrainemisdiagnosissinusitis

Autor:innen und Institutionen

  • University of Washington CHOICE Institute, Seattle, Washington, USA.
  • AbbVie, Irvine, California, USA.
  • The Los Angeles Headache Centers, Los Angeles and San Diego, California, USA.
  • AbbVie, North Chicago, Illinois, USA.
  • AbbVie, Madison, New Jersey, USA.

Förderung

  • AbbVie

Zitieren

APA

Kim, J. R., Park, T. J., Agapova, M., Blumenfeld, A., Smith, J. H., Shah, D., & Devine, B. (2025). Healthcare resource use and costs associated with the misdiagnosis of migraine. Headache: The Journal of Head and Face Pain, 65(1), 35-44. https://doi.org/10.1111/head.14822

Vancouver

Kim JR, Park TJ, Agapova M, Blumenfeld A, Smith JH, Shah D, et al. Healthcare resource use and costs associated with the misdiagnosis of migraine. Headache: The Journal of Head and Face Pain. 2025;65(1):35-44. doi:10.1111/head.14822

BibTeX
@article{Kim2025,
  author = {Kim, Jae Rok and Park, Tae Jin and Agapova, Maria and Blumenfeld, Andrew and Smith, Jonathan H and Shah, Darshini and Devine, Beth},
  title = {Healthcare resource use and costs associated with the misdiagnosis of migraine},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2025},
  volume = {65},
  number = {1},
  pages = {35--44},
  doi = {10.1111/head.14822}
}
Kostenlos starten →